Dyne Therapeutics, Inc.
DYN
$18.29
-$0.37-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -446.21M | -423.80M | -412.89M | -367.13M | -317.42M |
| Total Depreciation and Amortization | 2.05M | 1.98M | 1.89M | 1.79M | 1.67M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.36M | 43.29M | 40.30M | 35.88M | 42.87M |
| Change in Net Operating Assets | -3.40M | 2.82M | 11.13M | 9.74M | -19.49M |
| Cash from Operations | -403.21M | -375.71M | -359.56M | -319.73M | -292.37M |
| Capital Expenditure | -20.71M | -21.30M | -2.37M | -3.17M | -2.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.04M | -24.44M | -24.81M | -19.62M | -201.70M |
| Cash from Investing | -28.75M | -45.74M | -27.18M | -22.78M | -204.08M |
| Total Debt Issued | 148.26M | 98.80M | 98.80M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 742.61M | 364.73M | 164.86M | 542.75M | 809.90M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -558.00K | -549.00K | -- | -- | -- |
| Cash from Financing | 890.31M | 462.98M | 263.66M | 542.75M | 809.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 458.35M | 41.53M | -123.08M | 200.24M | 313.45M |